DRF 4367

Known as: DRF-4367, DRF4367 
 

Topic mentions per year

Topic mentions per year

2003-2005
01220032005

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
DRF-4367 is a novel COX-2 inhibitor, which showed good efficacy in several animal models of inflammation. In a comparative in… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2006
2006
A specific, accurate, precise and reproducible high performance liquid chromatography (HPLC) method was developed and validated… (More)
Is this relevant?
2006
2006
The purpose of the present study was to investigate the influence of a polyhydroxy base, N-acetyl glucamine (also know as… (More)
Is this relevant?
2006
2006
For pharmacokinetic and toxicokinetic purpose a simple HPLC-UV method has been developed and validated for the estimation of DRF… (More)
Is this relevant?
2005
2005
A simple, precise and accurate isocratic reverse-phase liquid chromatography method with programmed wavelength detection has been… (More)
Is this relevant?
2005
2005
The aim of this study was to characterize the pharmacokinetics and determine the absolute bioavailability and metabolism of DRF… (More)
Is this relevant?
2004
2004
A specific, accurate, precise and reproducible high-performance liquid chromatography (HPLC) method was developed for the… (More)
Is this relevant?
2004
2004
Analogs of 1,5-diarylpyrazoles with a novel pharmacophore at N1 were designed, synthesized and evaluated for the in-vitro… (More)
Is this relevant?
2003
2003
The pharmacokinetic characterization of DRF-4367 (a new diaryl pyrazole derivative), a potent selective COX-2 inhibitor was… (More)
  • figure 1
  • table I
  • figure 2
  • figure 3
Is this relevant?